Explain How Rexulti Compares to Other Atypical Antipsychotics
July 2017
Rexulti (REK-suhl-tee, brexpiprazole) will be another oral atypical antipsychotic for treating schizophrenia in adults.
It's a partial dopamine agonist similar to aripiprazole (Abilify)...but with slightly LESS dopamine agonist activity. This may lead to fewer dopamine-related side effects, such as akathisia or restlessness.
Rexulti is given once daily...like most other oral atypicals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive